CBT vs FUL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 26, 2026

CBT

63.0
AI Score
VS
CBT Wins

FUL

60.7
AI Score

Investment Advisor Scores

CBT

63score
Recommendation
HOLD

FUL

61score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CBT FUL Winner
Forward P/E 9.9404 9.4429 FUL
PEG Ratio 1.0017 2.2026 CBT
Revenue Growth 6.4% 5.2% CBT
Earnings Growth -93.7% 18.0% FUL
Tradestie Score 63.0/100 60.7/100 CBT
Profit Margin 5.2% 5.6% FUL
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CBT 1M: -7.1% · 3M: -12.2% FUL 1M: -6.9% · 3M: -14.0%

Current Technical Phase

CBT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.7%), weak momentum, RSI 37

RSI (14): 37.4 · Price: $76.95

FUL

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.6%), weak momentum, RSI 38

RSI (14): 37.5 · Price: $50.20

Fundamentals Snapshot

Metric CBT FUL
Market Cap — —
Forward P/E 11.0 9.7
Trailing P/E 21.6 13.8
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.2% 0.3%
Operating Margin 0.1% 0.1%
EPS 3.54 3.65
Dividend Yield 0.02% 0.02%

Frequently Asked Questions

Based on our detailed analysis, CBT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.